Skip to main content

Table 4 Resolutions for the barriers to rate control of intravenous (IV) medications suggested by the included studies

From: Attributes of errors, facilitators, and barriers related to rate control of IV medications: a scoping review

Categories by NCC MERPa

Resolutions for the barriers to rate control of IV medications

Human factors

- Appropriate monitoring and equipment check of the HCPs in the anesthetic department [20]

- Supervision by a specialist and skilled assistance in the anesthetic department [20]

- Rising anesthetists’ awareness of the continued integrity of vascular access systems [21]

- Checking correct tip placement and labels of lines by the HCPs in the anesthetic department [21]

- Establishing a stronger pharmacology knowledge base for nursing students and nurses [38]

- Raising HCPs’ awareness to ensure appropriate setup, maintenance, and integration of smart pumps [35]

Design

- Supply products with a high safety standard by the manufacturers [23]

- Short-term and long-term software and hardware changes to address failure modes with the new infusion pump [24]

- The use of the appropriate site-specific drug profile through the new infusion pump [24]

- Integration with barcoding and CPOE with the smart pump [26]

- Incorporating real-time vital signs and laboratory data with the smart pump [26]

- Automating monitoring and titration tasks with the smart pump [26]

- Careful development and testing of smart pumps [26]

- Drug dictionary in smart pumps reviewed by interdisciplinary committee members routinely and maintained up-to-date, evidence-based practice [30]

- Assessing smart pump logs by the biomedical engineering department [30]

- Investigating either physical or mechanical issues or human errors related to smart pumps by the biomedical engineering department [30]

- Using smart pumps as part of an integrated system with barcode scanning and interfacing with electronic systems and reducing reliance on gravity feed [33]

Contributing factors (system related)

- Coordinated approach from practitioners, regulators, and the pharmaceutical industry [23]

- Training for end users of the new infusion pump [24]

- Healthcare FMEA between multiple institutions for discussion of best practices among pediatric oncology centers [25]

- Different safety systems tailored for outpatient and inpatient chemotherapy settings [25]

- Increased communication between adult and pediatric chemotherapy delivery systems to prevent similar errors from occurring [25]

- A multidisciplinary approach that involves a change in hospital culture [28]

- Collaboration with pharmacists to implement evidence-based interventions [28]

- Increased training and supervision of new nurse graduates [40]

- More obstetricians and nurses during the night shifts [2]

- Improving nurses’ working procedures and implementing a clinical decision support tool that generates recommendations about adequate infusion rates [29]

- Implementation of BCMA and e-MAR [29]

- Integrated systems that are successfully implemented and utilized to get the full benefits of the safety system [30]

- Reviewing reports related to smart pumps by the patient safety committee [30]

- Hospital leadership working with a smart pump vendor to improve their products [30]

- Changing work practices (taking more time for drug administration, using short infusions to administer some medication) [37]

- Promoting a safety culture around medication, including drug preparation and administration [37]

- Implementation of electronic prescribing systems, barcode medication administration, and pharmacist-led training program [37]

- Multidisciplinary team with strong leadership endorsed by hospital managers for successful quality improvement [37]

- Interventions that are more automated and less reliant on human memory and vigilance to prevent interruption-related errors [31]

- Providing standard work conditions, such as a standard ratio of nurses to patients by hospital managers [38]

- Improving the relationship between the nurses and physicians by hospital managers [38]

- Facilitating the 24-h presence of clinical pharmacology experts for responding to medication questions by hospital managers [38]

- Interoperability between currently implemented healthcare information technologies [32]

- Implementation of point and calling methods and increasing compliance [39]

- Development and implementation of the intervention bundle developed incorporating the expertise of the multidisciplinary research team [34]

- A multidisciplinary approach when evaluating and procuring infusion pump [35]

- A process to regularly collect safety-related-data, review the data, and create solutions to address pump-related concerns [35]

- A multidisciplinary approach to identify and implement effective interventions to prevent medication-related harm in children [36]

  1. BCMA Barcode medication administration, CPOE Computerized physician order entry, e-MAR Electronic medication administration record, FMEA Failure mode and effect analysis, HCP Healthcare providers
  2. aCategories by NCC MERP: classified by medication error category according to NCC MERP [14]